Related Experiment Video

Updated: Jun 22, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis

A M Silva1, A Bettencourt, C Pereira

  • 1Departamento de Neurologia, Centro Hospitalar do Porto-Hospital de Santo António, Porto, Portugal. anadmsilva@yahoo.com

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 2, 2009
PubMed
Abstract

Insights

Human leukocyte antigen (HLA) HLA-DRB1*15 increases multiple sclerosis (MS) risk, while HLA-A*02 decreases it. This study investigated HLA class I and II associations in Portuguese MS patients, finding HLA-A*02

Area of Science:

  • Immunogenetics
  • Neuroimmunology
  • Human Genetics

Background:

  • Multiple sclerosis (MS) is linked to human leukocyte antigen (HLA) HLA-DRB1*15.
  • Emerging research implicates CD8 T cells in MS pathogenesis, suggesting a role for HLA class I molecules.
  • Previous studies noted associations between HLA-A*02 and HLA-A*03 alleles and MS.

Purpose of the Study:

  • To investigate the independent effects of HLA-A*02 and HLA-A*03 on MS risk in a Portuguese cohort.
  • To determine if the observed HLA associations were independent of the known HLA-DRB1*15 risk factor.

Main Methods:

  • Logistic regression analysis was employed to assess allele associations.
  • The study analyzed HLA-A*02 and HLA-A*03 influences, controlling for HLA-DRB1*15.
  • An interaction term between HLA-A*02 and HLA-DRB1*15 was evaluated.

Main Results:

  • HLA-DRB1*15 was confirmed as a significant risk factor for MS.
  • HLA-A*02 demonstrated a protective effect, decreasing MS risk.
  • HLA-A*03 showed no significant association with MS risk.
  • No significant interaction was found between HLA-A*02 and HLA-DRB1*15.

Conclusions:

  • HLA-DRB1*15 is a key genetic risk factor for MS.
  • HLA-A*02 may confer protection against MS development.
  • The protective effect of HLA-A*02 appears independent of HLA-DRB1*15.
  • Further research into HLA class I and II roles in MS is warranted.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...